An Anti-Wnt-2 Monoclonal Antibody Induces Apoptosis in Malignant Melanoma Cells and Inhibits Tumor Growth

Activation of the Wnt/β-catenin signaling pathway has been associated with human cancers. To test whether Wnt-2 signal is a survival factor in human melanoma cells and thus represents a potential therapeutic target, we investigated the effects of inhibition of Wnt-2 signaling in human melanoma cell lines. We have developed a novel monoclonal antibody against the NH2 terminus of the human Wnt-2 ligand that induces apoptosis in human melanoma cells overexpressing Wnt-2. Whereas incubation of this antibody with normal cells lacking Wnt-2 expression does not induce apoptosis, Wnt-2 signaling blockade by the ligand-binding antibody is confirmed by down-regulation of Dishevelled and β-catenin. Wnt-2 small interfering RNA treatment in these cells yielded similar apoptotic effects and downstream changes. Down-regulation of an inhibitor of apoptosis family protein, survivin, was observed in both the Wnt-2 antibody-treated and small interfering RNA-treated melanoma cell lines, suggesting that the antibody induces apoptosis by inactivating survivin. In an in vivo study, this monoclonal anti-Wnt-2 antibody suppresses tumor growth in a xenograft model. These findings suggest that the anti-Wnt-2 monoclonal antibody may be useful for the treatment of patients with malignant melanoma.

[1]  Biao He,et al.  Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression , 2003, Oncogene.

[2]  R. Holcombe,et al.  Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features , 2003, Molecular pathology : MP.

[3]  Jeffrey D. Axelrod,et al.  A Second Canon , 2003 .

[4]  K. Uematsu,et al.  Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. , 2003, Cancer research.

[5]  R. Holcombe,et al.  Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma , 2002, Molecular pathology : MP.

[6]  K. Uematsu,et al.  Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. , 2002, Molecular cancer therapeutics.

[7]  M. Daemen,et al.  The wnt-frizzled cascade in cardiovascular disease. , 2002, Cardiovascular research.

[8]  M. Daidone,et al.  Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[9]  T. Tuschl,et al.  Analysis of gene function in somatic mammalian cells using small interfering RNAs. , 2002, Methods.

[10]  M. Katoh.  Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. , 2001, International journal of oncology.

[11]  H. Clevers,et al.  The β-catenin–TCF-1 pathway ensures CD4+CD8+ thymocyte survival , 2001, Nature Immunology.

[12]  J. Nathans,et al.  Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains , 2001, Nature.

[13]  S. Galandiuk,et al.  Wingless‐type frizzled protein receptor signaling and its putative role in human colon cancer , 2001, Molecular carcinogenesis.

[14]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[15]  S. Srinivasula,et al.  Molecular Determinants of the Caspase-promoting Activity of Smac/DIABLO and Its Role in the Death Receptor Pathway* , 2000, The Journal of Biological Chemistry.

[16]  Xiaodong Wang,et al.  Structural and biochemical basis of apoptotic activation by Smac/DIABLO , 2000, Nature.

[17]  R Grosschedl,et al.  Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. , 2000, Immunity.

[18]  K. Kinzler,et al.  The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. , 2000, Cancer research.

[19]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[20]  J. McNiff,et al.  Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. , 1999, The Journal of investigative dermatology.

[21]  A. Harris,et al.  Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer , 1999, British Journal of Cancer.

[22]  S. Byers,et al.  Exogenous Expression of β-Catenin Regulates Contact Inhibition, Anchorage-Independent Growth, Anoikis, and Radiation-Induced Cell Cycle Arrest , 1999, The Journal of cell biology.

[23]  J. Nathans,et al.  Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Fengzhi Li,et al.  Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.

[25]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[26]  A. Harris,et al.  Compartment switching of WNT-2 expression in human breast tumors. , 1996, Cancer research.

[27]  C. Gespach,et al.  Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. , 1996, Oncogene.

[28]  A. Harris,et al.  Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. , 1994, Cancer research.

[29]  R. Nusse,et al.  Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. , 1992, Oncogene.

[30]  D. Altieri,et al.  Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic Targets , 2004, Cancer and Metastasis Reviews.

[31]  Randall T Moon,et al.  A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. , 2003, Developmental cell.

[32]  H Clevers,et al.  The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. , 2001, Nature immunology.

[33]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[34]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.